Huntington National Bank Eli Lilly & CO Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Huntington National Bank holds 297,449 shares of LLY stock, worth $235 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares

297,449

Previous 296,854 0.2%

Holding current value

$235 Million

Previous $269 Million 1.95%

% of portfolio

1.95%

Previous 2.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $459,423 - $571,211	595 Added 0.2%	297,449 $264 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $6.42 Million - $8.05 Million	-8,858 Reduced 2.9%	296,854 $269 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $2.06 Million - $2.76 Million	3,478 Added 1.15%	305,712 $238 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $2.75 Million - $3.24 Million	-5,232 Reduced 1.7%	302,234 $176 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $4.08 Million - $5.63 Million	-9,396 Reduced 2.97%	307,466 $165 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $12.8 Million - $17.1 Million	36,448 Added 13.0%	316,862 $149 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $693,326 - $814,278	-2,232 Reduced 0.79%	280,414 $96.3 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $288,751 - $336,453	898 Added 0.32%	282,646 $103 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $132,230 - $150,690	446 Added 0.16%	281,748 $91.1 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $2.7 Million - $3.17 Million	9,689 Added 3.57%	281,302 $91.2 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $4.01 Million - $4.99 Million	17,095 Added 6.72%	271,613 $77.8 Million
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $2.96 Million - $3.67 Million	13,156 Added 5.45%	254,518 $70.3 Million
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $611,616 - $752,679	2,760 Added 1.16%	241,362 $55.8 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $2.13 Million - $2.76 Million	11,807 Added 5.21%	238,602 $54.8 Million
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $1.61 Million - $2.09 Million	9,817 Added 4.52%	226,795 $42.4 Million
Q4 2020 Jan 11, 2021	BUY	$130.46 - $172.63 $441,346 - $584,007	3,383 Added 1.58%	216,978 $36.6 Million
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $1.29 Million - $1.49 Million	8,789 Added 4.29%	213,595 $31.6 Million
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $6.43 Million - $7.74 Million	47,129 Added 29.89%	204,806 $33.6 Million
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $6.79 Million - $8.41 Million	57,043 Added 56.68%	157,677 $21.9 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $466,171 - $577,394	-4,360 Reduced 4.15%	100,634 $13.2 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $363,299 - $395,176	-3,402 Reduced 3.14%	104,994 $11.7 Million
Q2 2019 Jul 23, 2019	BUY	$110.79 - $129.32 $19,831 - $23,148	179 Added 0.17%	108,396 $12 Million
Q1 2019 Apr 09, 2019	SELL	$111.31 - $131.02 $401,606 - $472,720	-3,608 Reduced 3.23%	108,217 $14 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $5.45 Million - $6.1 Million	-51,417 Reduced 31.5%	111,825 $12.9 Million
Q3 2018 Oct 18, 2018	SELL	$85.86 - $107.31 $267,539 - $334,377	-3,116 Reduced 1.87%	163,242 $17.5 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $111,581 - $128,061	-1,474 Reduced 0.88%	166,358 $14.2 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $801,096 - $945,641	-10,795 Reduced 6.04%	167,832 $13 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $553,422 - $593,609	-6,754 Reduced 3.64%	178,627 $15.1 Million
Q3 2017 Oct 24, 2017	BUY	$77.07 - $85.54 $14.3 Million - $15.9 Million	185,381	185,381 $15.9 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Eli Lilly & CO Transaction History